The Narcotics Control Commission (NACOC) will soon begin implementing Ghana’s licensing regime for medicinal and industrial cannabis cultivation, following Parliament’s approval of the regulatory and cost framework.
In a press statement dated February 11, 2026, and signed by Francis Opoku Amoah, Acting Director of Public Affairs and International Relations, NACOC announced that it will operationalise the licensing regime for controlled cultivation, processing, and use of cannabis with tetrahydrocannabinol (THC) content not exceeding 0.3 per cent.
NACOC emphasised that licenses will only be granted to qualified entities that meet stringent requirements, including security protocols, product traceability systems, quality assurance standards, and full compliance with applicable laws and regulations.
The Commission strongly cautioned prospective applicants to deal directly and exclusively with NACOC through the Cannabis Regulations Department (CRD), warning them to avoid engaging with any individuals, groups, or associations claiming to facilitate licensing.
“Follow only the officially approved licensing processes and guidelines,” the statement advised.
NACOC was emphatic that recreational use of cannabis remains illegal in Ghana despite the new licensing framework for medicinal and industrial purposes.
“NACOC reiterates that recreational use of cannabis remains illegal in Ghana,” the statement stressed.
The Commission indicated it will work closely with relevant ministries, departments, and agencies, including the Ministry of Interior, Ghana Standards Authority, and the Food and Drugs Authority, to ensure effective implementation, monitoring, and enforcement of the framework.
“We remain committed to safeguarding public health and safety while supporting lawful innovation and industrial development in Ghana,” the NACOC statement concluded.
The regulatory framework allows for the controlled cultivation of low-THC cannabis (0.3 percent or less), which is typically used for industrial purposes such as fibre production, cosmetics, and certain medicinal applications, while maintaining strict prohibitions on high-THC cannabis associated with recreational use.
